Page last updated: 2024-09-05

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Experimental Mammary Neoplasms

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coley, HM; Twentyman, PR; Workman, P1
Marquardt, H; Mohr, U; Westendorf, J1

Other Studies

2 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Experimental Mammary Neoplasms

ArticleYear
9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:6

    Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Neoplasm Proteins; Tumor Cells, Cultured

1990
Induction of malignant transformation in vitro and mammary tumors in rats by two new potent anthracycline antitumor antibiotics, morpholinodaunomycin and cyanomorpholinoadriamycin.
    Cell biology and toxicology, 1987, Volume: 3, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Carcinogenicity Tests; Cell Transformation, Neoplastic; Cells, Cultured; Cricetinae; Cricetulus; Daunorubicin; Doxorubicin; Female; In Vitro Techniques; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains

1987